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Thiazolidinediones (TZDs) are PPARg activators that
exhibit vasculoprotective properties. To determine
the vascular function of PPARg, we analyzed Tie2-
Cre/flox and SM22Cre/flox mice. Unexpectedly,
both knockout strains exhibited a significant reduc-
tion of circadian variations in blood pressure and
heart rate in parallel with diminished variations in
urinary norepinephrine/epinephrine excretion and
impaired rhythmicity of the canonical clock genes,
including Bmal1. PPARg expression in the aorta
exhibited a robust rhythmicity with a more than
20-fold change during the light/dark cycle. Rosiglita-
zone treatment induced aortic expression of Bmal1
mRNA, and ChIP and promoter assays revealed
that Bmal1 is a direct PPARg target gene. These
studies have uncovered a role for vascular PPARg
as a peripheral factor participating in regulation of
cardiovascular rhythms.
INTRODUCTION
The internal molecular clock drives circadian rhythms of physiol-
ogy and behavior in most organisms in order to adapt to a chang-
ing environment. Over the past decade, much progress has been
made in understanding the molecular basis of circadian rhythms.
The master regulator of circadian rhythms is thought to reside in
the suprachiasmatic nucleus (SCN), a group of neurons express-
ing an autoregulatory transcription-translation-based feedback
loop. In the simplest form, the heterodimers of the basic helix-
loop-helix Per Arnt Sim transcription factors, CLOCK and
Bmal1, drive the rhythmic expression of three period genes
(mPer1–3) and two Cryptochrome genes (mCry1 and mCry2)
through E box enhancer elements (Reppert and Weaver, 2001,
2002; Young and Kay, 2001). As the mPer and mCry proteins
are translated, they form multimeric complexes that are translo-
cated to the nucleus. In the nucleus, mCry proteins directly inter-
act with CLOCK and/or Bmal1 to inhibit transcription, resulting in
the formation of a negative feedback loop (Kume et al., 1999).
Emerging evidence suggests that molecular ‘‘clocks’’ also exist482 Cell Metabolism 8, 482–491, December 3, 2008 ª2008 Elsevierin peripheral tissues and that they operate in the same way as
in SCN neurons (Balsalobre et al., 1998; McNamara et al.,
2001; Oishi et al., 1998a, 1998b). Various components of the
clock system have been identified in liver, kidney, heart, and
blood vessels (Zylka et al., 1998) and even in immortalized rat fi-
broblast cells that have been kept in culture for more than
25 years (Balsalobre et al., 1998). Approximately 8%–10% of
the total number of genes expressed in mouse heart and liver ex-
hibit a circadian expression pattern (Storch et al., 2002). How-
ever, the majority of these studies have been descriptive in
nature. To address the circadian function in individual tissues,
it is essential to use a tissue-specific approach such as the
Cre-loxP recombination system. This conclusion is reflected in
the recent generation of CLOCK floxed mice, which offer
a unique tool to study molecular clock functions in a tissue-spe-
cific manner (DeBruyne et al., 2006). The mice were initially used
to produce whole-body knockouts of CLOCK, which unexpect-
edly exhibited normal circadian phenotypes (DeBruyne et al.,
2006), challenging the central role of CLOCK:Bmal1 hetero-
dimers in clock function.
Circadian variations in blood pressure (BP) and heart rate (HR)
are among the best recognized circadian rhythms of physiology.
In humans, there is a sharp rise in BP before awakening with
highest values around midmorning. Many cardiovascular events,
such as sudden cardiac death, myocardial infarction, and stroke,
display diurnal variations with an increased incidence in the early
morning hours, which may correlate with the morning surge in BP
(Muller, 1999a, 1999b). On the other hand, the reduction of the
decline in nocturnal BP has been suggested to be a strong pre-
dictor of cardiovascular events and end-organ damage in both
hypertensive patients and the normotensive population (Ohkubo
et al., 2002). As in many other peripheral tissues, the circadian
expression of clock genes was well demonstrated in the cardio-
vascular system (Durgan et al., 2005; Maemura et al., 2000; Non-
aka et al., 2001; Portman, 2001; Rudic et al., 2005; Takeda et al.,
2007; Young and Kay, 2001), but the biological significance of
this phenomenon remains unclear.
Peroxisome proliferator-activated receptor-g (PPARg) is
a member of the superfamily of nuclear receptor ligand-activated
transcription factors and is best known for serving as a molecular
target for thiazolidinediones (TZDs), including rosiglitazone
(RGZ) and pioglitazone, that are widely prescribed and highly
effective for treatment of type 2 diabetes. Compelling evidenceInc.
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Circadian Function of Vascular PPARgFigure 1. Validation of PPARg Deletion in the Vascular Cells
(A) Schematic illustration of primer design for detection of the PPARg foxed allele (S1 and AS1) and PPARg mRNA expression (S2 and AS2).
(B) PCR analysis of the PPARg floxed allele in ECs and VSMCs freshly isolated from PPARgf/f (f/f), SM22Cre/flox (SM22), and Tie2Cre/flox (Tie2) mice using
primers S1 and AS1. Amplification of GAPDH gene served as a loading control.
(C) RT-PCR analysis of PPARg mRNA in ECs and VSMCs from the three strains of mice. CD31 and a-SMA are markers of EC and SMC, respectively.
a-Tubulin was used as a loading control. Shown are representatives of 2–3 experiments.from both pharmacological and genetic studies has established
a pivotal role of this nuclear receptor in the control of glucose and
lipid metabolism (Berger et al., 2005; Evans et al., 2004). Apart
from their metabolic activity, TZDs exert vasculoprotective ef-
fects through poorly characterized mechanisms. The present
study describes the use of conditional knockout mice to deter-
mine the circadian function of vascular PPARg.
RESULTS
Validation of Conditional Deletion of PPARg
Both Tie2Cre/flox and SM22Cre/flox mice were born at the ex-
pected Mendelian ratio, and neither mutant had gross morpho-
logical abnormalities in adults (Table S1 available online). Of
note, sporadic alopecia was found in young, but not adult, Tie2-
Cre/flox mice. DNA recombination and mRNA expression analy-
ses of the PPARg gene were evaluated in freshly isolated ECs
and vascular smooth muscle cells (VSMCs) from both KO strains
together with their floxed controls. Primers S1 and AS1 flank the
loxP site and amplify a product of 152 bp from the floxed allele,
but not the recombined allele (Figure 1A). Primers S2 and AS2
are located in separate exons and are 10 kb apart, and the re-
sulting product of 209 bp is derived from PPARg mRNA, but not
genomic DNA. Isolation of ECs and VSMCs was based on
controlled digestion with collagenase. The SMC marker a-SMA
was detected in VSMCs, but not ECs. Conversely, the EC marker
CD31 was observed in ECs, but not VSMCs (Figures 1B and 1C),
thus confirming the purity of our preparations. Using PCR, we
verified that the PPARg floxed allele was deleted in ECs, but
not VSMCs, of Tie2Cre/flox mice and in VSMCs, but not ECs,
of SM22Cre/flox mice (Figure 1B). RT-PCR analyses established
that a similar pattern of PPARg mRNA expression existed in the
two KO strains as that described earlier for DNA recombination
(Figure 1C). Real time-PCR indicated that the aorta from
SM22Cre/flox mice and the vena cava from Tie2Cre/flox mice
exhibited the greatest reduction of the floxed allele (Figure S1).
These findings likely are due to the large smooth muscle and
endothelial compartments in arteries and veins, respectively.
Echocardiographic (Table S2) and hematoxylin and eosin (HE)Cellanalyses (data not shown) indicate that the SM22 promoter
did not precipitate any cardiac abnormalities in SM22Cre/flox
mice. Lastly, because plasma glucose, cholesterol, and triglyc-
erides (Table S1) and glucose tolerance (Figure S2) were similar
among Tie2Cre/flox and SM22Cre/flox mice and their respective
controls, we believe that PPARg signaling was intact in meta-
bolic tissues such as liver, fat, and skeletal muscles.
Characterization of the Circadian Phenotype
Telemetry was performed to analyze circadian variations in MAP
and HR in Tie2Cre/flox and SM22Cre/flox mice. As expected, te-
lemetry data from the floxed mice showed nocturnally activated
circadian rhythms of MAP and HR that were significantly higher
during the dark versus light phase (Figures 2A, 2B, 2D, and 2E).
When compared to floxed mice, SM22Cre/flox animals exhibited
higher MAP and HR during the light cycle, but not during the dark
cycle. A different pattern was observed in Tie2Cre/flox mice. The
changes in MAP and HR in Tie2Cre/flox mice appeared to be dis-
sociated with a reduction of MAP during the dark phase but an
increase in HR during both phases relative to floxed mice. Taken
together, the diurnal variations of MAP and HR were blunted in
the two mutant strains versus floxed controls (Figures 2C and
2F). Given the central role of sympathetic nerve activity in the
generation of cardiovascular frequency, we determined urinary
norepinephrine (NE) and (epinephrine) Epi during the light and
dark phases. The diurnal variations of urine output in either
mutant mouse line were not different than their floxed controls
(PPARgf/f: day 0.56 ± 0.12 ml versus night 1.7 ± 0.32 ml;
SM22Cre/flox: day 0.57 ± 0.11 ml versus night 1.58 ± 0.26 ml;
Tie2Cre/flox: day 0.77 ± 0.15 ml versus night 1.45 ± 0.2 ml; N =
6–7 in each group). In the floxed control mice, urinary NE and
Epi excretion exhibited a robust variation (>10-fold) during the
light/dark (LD) cycle, but this variation was diminished markedly
in SM22Cre/flox and Tie2Cre/flox animals (Figures 3A–3D).
Interaction of PPARg with Bmal1 in the Blood Vessels
In support of the circadian function of vascular PPARg, RT-PCR
analyses of PPARg expression in the aortae of PPARgf/f mice ex-
hibited a more than 20-fold change during the light/dark cycleMetabolism 8, 482–491, December 3, 2008 ª2008 Elsevier Inc. 483
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Circadian Function of Vascular PPARgFigure 2. Altered Diurnal Rhythms in MAP and HR in SM22Cre/Flox and Tie2Cre/Flox Mice
(A) Hourly recordings of MAP over 24 hr. CT0, the beginning of a subjective circadian period (6:00 AM).
(B) The average MAP during light and dark phases.
(C) The maximal variations of MAP over 24 hr.
(D) Hourly recordings of HR over 24 hr.
(E) The average HR during light and dark phases.
(F) The maximal variations of HR over 24 hr.
N = 5–7 in each group. Data are mean ± SE.with a peak level at CT16 preceding the induction of Bmal1, while
hepatic PPARg exhibited a distinct pattern of diurnal variation
with a peak level at CT8 (Figure 4A). In the floxed mice, aortic ex-
pression of canonical clock genes exhibited typical circadian
variations with the transcription factors Bmal1 and CLOCK peak-
ing at CT20 and other clock genes Cry1, Cry2, and Per2 at CT8
(Figures 4B–4F). The amplitude of Bmal1 expression was signif-
icantly reduced in both SM22Cre/flox and Tie2Cre/flox mice
compared to controls, in parallel with the suppressed amplitude
of Cry1, Cry2, and Per2 in the mutant strains. Despite the re-
duced amplitude of the circadian rhythm, significant circadian
variations were detected for Bmal1 in SM22Cre/flox mice and
for all circadian genes in Tie2Cre/flox mice. A different pattern
was observed for CLOCK. The circadian variation of CLOCK
was significantly suppressed in Tie2Cre/flox mice but appeared
to be well preserved in SM22Cre/flox mice. Since NPAS2
(MOP4) was reported to be able to functionally substitute for
CLOCK in the master brain clock in mice to regulate circadian
rhythmicity (DeBruyne et al., 2007), we determined NPAS2 ex-
pression in the aortae of the SM22Cre/flox and Tie2Cre/flox
mice. In the floxed controls, the aortic expression of NPAS2 ex-
hibited robust variations that were significantly blunted in both
mutant mice (Figure S3A). Additionally, in the floxed control
mice, the aortic expression of the vasoconstrictor a1d-adrener-484 Cell Metabolism 8, 482–491, December 3, 2008 ª2008 Elseviergic receptor (a1dAR) and vasodilator b1AR exhibited opposite cir-
cadian regulation patterns: a1dAR peaked at CT0, decreased at
CT8, and remained at low levels at CT 20, whereas b1AR was
detected at the lowest levels at CT0 that gradually increased.
As compared with the floxed controls, the circadian rhythms of
the adrenoceptor subtypes were altered in both mutant mice.
In particular, the circadian variations in a1dAR in the aortae
were remarkably suppressed in SM22Cre/flox mice.
In contrast to the overall blockade of the rhythms of the clock
genes in the vasculature of the PPARg mutant mice, the rhythms
in the liver were well preserved (Figures 4G–4I). Indeed, none of
the diurnal rhythms of locomotor activity or metabolism were
affected in either one of the PPARg mutant strains (Figure S4).
Subsequently, we performed a series of experiments to test
whether PPARg functioned as a direct regulator of Bmal1 in
the vasculature. Following treatment with RGZ, the aortic ex-
pression of Bmal1 was significantly elevated (Figure 5A). ChIP
assay performed on the aortae of RGZ-treated mice revealed
a direct physical interaction between PPARg and the Bmal1 pro-
moter that contains a PPRE site (Figure 5B). When transfected in
SVEC4-10 cells (a mouse endothelial cell line), a 239 bp fragment
of mouse Bmal-1 promoter containing the PPRE exhibited a sig-
nificant increase in promoter activity following exposure to 2 mM
RGZ (Figure 5C). This increase was completely abolished byInc.
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Circadian Function of Vascular PPARgFigure 3. Altered Diurnal Rhythms in Sympathetic Activity in SM22Cre/Flox and Tie2Cre/Flox Mice
(A) A 12 hr urine output of NE during light and dark phases.
(B) Night-to-day ratios of urinary NE.
(C) A 12 hr urine output of Epi.
(D) Night-to-day ratios of urinary Epi.
N = 6–7 in each group. Data are mean ± SE.mutagenesis of the PPRE site (Figure 5C). Similar results were
obtained with M1 cells (a mouse collecting duct cell line)
(Figure 5D). An exception is that mutagenesis of the PPRE site
led to reduced baseline luciferase activities in SVEC4-10, but
not M1 cells.
Light and Food Sensitivity of the Rhythmicity
of Vascular PPARg
It is thought that the SCN may entrain the rhythmic expression of
peripheral clock genes via neural or hormonal pathways (Buijs
and Kalsbeek, 2001). To test whether the oscillation of vascular
PPARg is under the influence of the SCN, we compared the di-
urnal pattern of vascular PPARg under changing light conditions.
Under the regular light/dark cycle, aortic PPARg exhibited a noc-
turnally activated expression pattern. In contrast, this rhythm
was reversed under constant lightness and diminished under
constant darkness (Figure 6A). Feeding is another important fac-
tor that exerts an influence on circadian oscillators in peripheral
cells (Damiola et al., 2000). Therefore, we determined the effect
of restricted feeding on the rhythmicity of vascular PPARg under
regular light-dark conditions. The pattern of diurnal variationsCellwith nighttime feeding (Figure 6B) was not different than that ob-
tained with unrestricted feeding. As nocturnal animals, mice con-
sume most of their food during the night. In contrast, the diurnal
pattern of vascular PPARg was reversed by the daytime feeding
(Figure 6B).
DISCUSSION
Although the SCN is classically viewed as the master regulator of
molecular clocks, it has become apparent that a similar system
exists in peripheral tissues (e.g., blood vessels). To obtain mo-
lecular insights into circadian functions existing in blood vessels,
we performed a parallel analysis of hemodynamic parameters in
two strains of mice with vascular PPARg deletions. Our most
important finding is that diurnal variations in hemodynamic
variables are blunted in both mutants relative to floxed controls.
Specifically, radiotelemetry of untethered animals showed
that circadian fluctuations in HR and BP were significantly re-
duced in both SM22Cre/flox and Tie2Cre/flox mice versus the
appropriate controls. These data provide in vivo evidence that
the circadian rhythms of BP and HR are, at least in part,Metabolism 8, 482–491, December 3, 2008 ª2008 Elsevier Inc. 485
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Circadian Function of Vascular PPARgFigure 4. RT-PCR Analysis of Gene Expressions in the Aortae and Livers of PPARgf/f, SM22Cre/Flox, and Tie2Cre/Flox Mice at 4 Hr Intervals
The x axis represents circadian time (CT0, the beginning of subjective light cycle).
(A) PPARg expression in PPARgf/f mice.
(B–I) Expressions of canonical clock genes in aortae and livers in the three mouse strains.
N = 5 in each time point. Shown are mean ± SE. *p < 0.05; #p < 0.01 versus PPARgf/f.regulated by a PPARg-dependent, peripheral mechanism intrin-
sic to the blood vessels. Systemic gene knockout studies have
established an essential role for Bmal1 and Cry1 and Cry2 in
control of the cardiovascular rhythms, but the data obtained
are unable to assign this role to a specific tissue type. In agree-
ment with the circadian function of vascular PPARg, pioglitazone
shifts the circadian rhythm of BP from nondipper to dipper type in
patients with type 2 diabetes (Anan et al., 2007). Moreover, upre-
gulation of PPARg as well as PPARa is associated with restora-
tion of this rhythm in obese insulin-resistant mice following a
24 hr fast (Verreth et al., 2004).
Sympathetic nerve activity is known to be an important regu-
lator of circadian variations in BP and HR. In particular, mice
lacking dopamine b hydroxylase (Dbh) are hypertensive and
lose circadian variability in BP (Swoap et al., 2004). In conjunc-
tion with the impairment of cardiovascular rhythmicity, the diur-
nal variations in urinary excretion of NE and Epi taken as esti-
mates of overall sympathetic tone were similarly suppressed in
both PPARg mutants. These findings are similar to those re-
ported to occur in Bmal1/ (Curtis et al., 2007) and Cry1/
Cry2/ (Masuki et al., 2005) mice. Moreover, we observed dis-
tinct patterns of circadian regulation of adrenoceptor subtypes
in the floxed aortae. a1dAR peaked at CT0 and gradually
decreased, whereas b1AR was detected at the lowest levels at486 Cell Metabolism 8, 482–491, December 3, 2008 ª2008 ElsevierCT0 and gradually increased. This coordinated regulation of
the adrenoceptor subtypes may be an important determinant
of the circadian variation of vascular tone, although recent
studies have shown maintained cardiovascular rhythmicity in
b1/b2AR-deficient mice (Kim et al., 2008). As compared with
the floxed controls, the circadian rhythms of the adrenoceptor
subtypes were altered in both mutant mice. In particular, the cir-
cadian variations in a1dAR in the aortae were remarkably sup-
pressed in SM22Cre/flox mice. These findings suggest that dys-
regulation of adrenoceptor subtypes in the mutant mice may
underlie the diminished circadian variations in BP and HR. Future
studies are needed to determine whether PPARg directly regu-
lates expression of vascular adrenoceptors or indirectly affects
the expression via Bmal1.
We present compelling evidence supporting PPARg as a direct
regulator of Bmal1 in the blood vessels. First, vascular PPARg
exhibits a robust oscillation that precedes Bmal1. Second,
PPARg deficiency in the blood vessels leads to effective block-
ade of the rhythmicity as well as the baseline expression of
Bmal1 in the aorta. Third, the PPARg activator RGZ induces aor-
tic expression of Bmal1. Fourth, a ChIP assay reveals a direct
physical interaction between PPARg and Bmal1 promoter.
Lastly, the Bmal1 promoter in both vascular and nonvascular
cells was responsive to RGZ, and this response was abolishedInc.
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Circadian Function of Vascular PPARgFigure 5. PPARg Regulates Bmal1 Gene Transcription
PPARgf/f mice were treated with RGZ at 320 mg/kg diet for 2 days. The thoracic aortae were harvested and subjected to RT-PCR (A) and ChIP assay (B). For
luciferase assay, mouse SVEC4-10 cells (C) and mouse M1 cells (D) were transiently transfected with constructs containing wild-type Bmal1 promoter or
Bmal1 promoter with mutated PPRE and cotransfected with expression vectors for PPARg, RXRa, and b-galactosidase. In (E), the PPRE site is shown in green,
and mutated sequences are indicated by lowercase letters. Confluent cells were exposed for 24 hr with vehicle or 2 mM RGZ. Luciferase activity was normalized
by b-galactosidase activity.
(A, C, and D) N = 4–5 per group; data are mean ± SE.
(B) The two lanes in each group represent two separate animals.by mutagenesis of the PPRE site. It is interesting to note that
PPARg deficiency in either ECs or SMCs produces a similar,
nearly complete blockade of rhythmicity of the canonical clock
genes. This may suggest a possible interplay between the two
types of vascular cells in accomplishing diurnal variations in
BP and HR. We suggest that PPARg in the two types of vascular
cells may interact with each other to form a functional unit of the
peripheral clock.
The SCN perceives light and entrains the rhythmic expression
of the clock genes in peripheral tissues via neural or hormonal
pathways (Buijs and Kalsbeek, 2001). The reversal of the diurnal
rhythm by changing the light/dark cycle indicates that the rhyth-
mic expression of vascular PPARg is light sensitive. These find-
ings represent indirect evidence that the circadian function of
vascular PPARg may be under the influence of the SCN. To
further address this possibility, future studies are needed toCellevaluate expression of vascular PPARg in SCN-lesioned ani-
mals. It was reported that changes in metabolism, such as re-
stricted feeding, can lead to an uncoupling of peripheral oscilla-
tors from the central pacemaker (Damiola et al., 2000). In
agreement of this notion, changes in feeding time, similar to
changes in the photoperiod, reset the phase of rhythmic expres-
sion of vascular PPARg. Overall, these data support a role for
vascular PPARg as a component of the peripheral clock.
Emerging evidence suggests a link between the circadian
rhythm and metabolism. A large number of human and animal
studies demonstrate that the circadian rhythms have a direct im-
pact on energy metabolism. Perturbations in circadian rhythms
in humans are associated with increased risk of obesity and hy-
perlipidemia (Karlsson et al., 2001). Reduced sleep duration in
children is associated with increased risk of being overweight
(Lumeng et al., 2007). Remarkably, the disruption of the coreMetabolism 8, 482–491, December 3, 2008 ª2008 Elsevier Inc. 487
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Circadian Function of Vascular PPARgFigure 6. Effects of Lightness/Darkness and Restricted Feeding on the Cyclic Expression of Vascular PPARg
(A) PPARg mRNA expression in the aortae of PPARgf/f mice kept under regular 12:12 hr LD, LL, or DD for 3 days.
(B) PPARg mRNA expression in the aortae of PPARgf/f mice kept under the regular LD cycle and fed only during the light or dark phase. All animals were killed at
CT4 and CT16, and aortic PPARg expression was determined by RT-PCR. N = 5 in each group. Shown are mean ± SEM.
(C) Proposed role of PPARg in integrating the environmental signals, the clock, the cardiovascular function, and metabolism.molecular clock machinery including Bmal1 and CLOCK leads to
hyperphagia and obesity, as well as metabolic syndrome char-
acterized by hyperleptinemia, hyperlipidemia, hepatic steatosis,
and hyperglycemia (Rudic et al., 2004; Turek et al., 2005). PPARg
is a key regulator of glucose and lipid metabolism (Berger et al.,
2005; Evans et al., 2004). The identification of the circadian func-
tion of PPARg by the present study has placed this nuclear re-
ceptor as a promising mediator between the circadian rhythm
and metabolism as illustrated in Figure 6C. Along this line,
a closely related member of the PPAR family, PPARa, which is
primarily involved in hepatic lipid metabolism, was reported to
regulate the peripheral oscillator of the liver by directly interact-
ing with Bmal1 (Canaple et al., 2006). Interestingly, the same
PPRE site at 1519 bp in the Bmal1 promoter confers the re-
sponse to both PPARa and PPARg activators. Together, these
data suggest that different PPAR subtypes may coordinate their
roles in integrating circadian rhythms and various aspects of me-
tabolism by targeting a common component of the peripheral
clock, e.g., Bmal1. The complexity of the system comes from
the report of Yang et al., who found that, among 45 nuclear re-
ceptors that are expressed in white and brown adipose tissue,
liver, and skeletal muscle, more than half exhibit rhythmicity
(Yang et al., 2006), thus suggesting involvement of the nuclear
receptor network in this phenomenon.
The present study is limited in that SM22 and Tie2 promoter
activities are not exclusively restricted to the vascular cells. For
example, SM22 promoter activity has been reported in the devel-
oping heart (Miano et al., 2004). Accordingly, a thorough analysis
of cardiac morphology and function in SM22Cre/flox mice was
performed but revealed no signs of cardiac hypertrophy or other
types of cardiac dysfunction, a phenotype clearly different than
mice with cardiomyocyte-specific deletion of PPARg (Duan
et al., 2005). The DNA recombination in the gastrointestinal tract
and bladder, which contain a rich smooth muscle compartment,
is expected, but these tissues would appear less relevant to the
cardiovascular phenotype. Similarly, although the Tie2 promoter
is quite extensively used for targeting ECs (Isermann et al., 2001;
Sabrane et al., 2005), Tie2 expression is found in hematopoietic
cells (Takakura et al., 1998). The Tie2-Cre model has been used
to inactivate PPARg in hematopoietic and endothelial cells, lead-
ing to alopecia, growth retardation, and osteoperosis (Wan et al.,488 Cell Metabolism 8, 482–491, December 3, 2008 ª2008 Elsevier2007a, 2007b). Although obvious gross morphological abnor-
malities were not noticed in our model, it is difficult to rule out
the possibility that some of these confounding factors may affect
vascular function.
In summary, mice with conditional deletion of PPARg using
Tie2-Cre and SM22-Cre developed abnormalities in circadian
variations in BP and HR, in parallel with a reduction of diurnal var-
iations in the sympathetic nerve activity, and impaired rhythmic-
ity of Bmal1 in the blood vessels. Furthermore, vascular PPARg
exhibits a robust cyclic expression, and PPARg activation stim-
ulates Bmal1 expression. Together, our studies have defined
PPARg as a key component of the vascular clock.
EXPERIMENTAL PROCEDURES
Transgenic Mouse Lines
PPARgf/f mice contain two loxP sites inserted into introns 1 and 2 of the PPARg
gene flanking the critical exon 2 by homologous recombination in ES cells. The
floxed mice were crossed with Tie2-Cre (Kisanuki et al., 2001) and SM22-Cre
mice (Holtwick et al., 2002), respectively, to yield mice homologous for the
floxed allele and heterozygous for the Cre transgene (termed Tie2Cre/flox
and SM22Cre/flox). Each Cre strain has been used to target respective vascu-
lar cells (Boucher et al., 2003; Frutkin et al., 2006; Hernando et al., 2007; Miano
et al., 2004; Xin et al., 2007). Genotypes were confirmed by PCR analysis as
described previously (Nicol et al., 2005; Zhang et al., 2005). All male mice at
3 to 4 months of age were maintained under 12:12 hr LD cycle (lights on at
6:00 AM and lights off at 6:00 PM) for at least 2 weeks before the day of exper-
iment. Mice fed during the day received food from 6:00 AM to 6:00 PM,
whereas mice fed during the night received food from 6:00 PM to 6:00 AM.
All procedures were in accordance with the guidelines approved by the Univer-
sity of Utah Institutional Animal Care and Use Committee.
Evaluation of DNA Recombination of PPARg
ECs and SMCs from KO mice and floxed controls were freshly isolated as pre-
viously described with modifications (Sutliff et al., 1999). Briefly, the thoracic
and abdominal aortae were dissected free of adherent tissue, removed from
the animal, and opened longitudinally. The layer of endothelium and the tunica
media were denuded with forceps, cut into 1 mm pieces, and incubated in
a physiological solution containing 0.8% collagenase A at 37C. The loosely
adhered cells were dislodged by repeated mixing with a pipette. Following
a 20 min incubation, these cells were determined to be ECs. After an additional
20 min incubation, the tunica media were collected and determined to be
enriched in VSMCs. The purity of these cells was evaluated using the SMC
marker a-SMA and the EC marker CD31. Isolated ECs and VSMCs wereInc.
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sion of PPARg.
Telemetry Recordings
The radiotelemetric device was implanted into male 3- to 4-month-old
PPARgf/f, SM22Cre/flox, and Tie2Cre/flox mice through catheterization of
the carotid artery (model no.: TA11PA-C20, DSI, MN) as previously described
(Jia et al., 2006). After allowing 1 week for recovery, BP, HR, and activity counts
were recorded for at least 48 hr to study the circadian variation of these
variables.
Analysis of Circadian Gene Expression
PPARgf/f, SM22Cre/flox, and Tie2Cre/flox mice kept under the LD cycle were
killed at 4 hr intervals over 24 hr, and thoracic and abdominal aortae and livers
were harvested for RT-PCR analysis of PPARg and canonical clock genes, in-
cluding Bmal1, CLOCK, Cry1–2, and Per2. The primer sequences are listed in
Table S3. RT-PCR amplification was performed using the SYBR Green Master
Mix (Applied Biosystems) and the Prism 7500 Real-Time PCR Detection Sys-
tem (Applied Biosystems). Cycling conditions were 95C for 10 min followed
by 40 repeats of 95C for 15 s and 60C for 1 min. For testing the effect of
PPARg activation on vascular Bmal1 expression, PPARgf/f mice were treated
with RGZ at 320 mg/kg diet for 5 days, and the aortae were harvested for anal-
ysis of Bmal1 expression. The diet was prepared as previously described
(Zhang et al., 2005). For testing light sensitivity of vascular PPARg expression,
PPARgf/f mice were kept under regular LD cycle, constant lightness (LL), or
constant darkness (DD) for 3 days as previously described (Kolker et al.,
2003). The animals were killed at CT4 and CT16, and aortae were harvested
for RT-PCR analysis of PPARg expression. Maximal variations of aortic PPARg
were found between these two circadian time points.
Chromatin Immunoprecipitation Assay
Mouse thoracic and abdominal aortae were harvested, cut into 1 mm pieces,
and crosslinked with 1% formaldehyde for 15 min. The tissues were lysed in an
SDS lysis buffer containing a protease inhibitor cocktail (Roche), and chroma-
tin was fragmented by sonication. The chromatin fraction was precleared with
salmon sperm DNA/protein A agarose and immunoprecipitated with PPARg
antibody (sc-7273X, Santa Cruz Biotechnology Inc.). The immunoprecipitated
mouse Bmal1 DNA is amplified by PCR with Bmal1 sense primer 50-ACTCAG
GGGAAGTGGGAAGT-30 and antisense primer 50-TGGACCAGCTCGTGTG
ACTA-30. The resulting PCR products of 187 bp were separated on a 2%
agarose gel and stained with ethidium bromide.
Construction of Plasmids
A 239 bp MluI/BglII fragment of mouse Bmal-1 promoter containing a PPRE
was amplified by PCR with sense primer, 50-TGGACGCGTACTCAGGGGA
AGTGGGAAGT-30, and antisense primer, 50-TGGAGATCTGGCTGGATCCA
TGAACAAAT-30. The PCR fragment was constructed into the MluI and BglII
site of pGL3-basic vector (Promega). The PPRE mutant plasmid was gener-
ated by the overlapping PCR technique and then ligated into the same site
of pGL3 plasmid. All constructs were purified using the Hispeed plasmid
Maxi kit (QIAGEN) and verified by DNA sequencing.
Transfection and Luciferase Reporter Gene Assay
M1 cells (a mouse cortical collecting duct cell line) and SVEC4-10 cells (a
mouse vascular endothelial cell line) were obtained from ATCC. At 70% con-
fluence, the cells, grown in a 12-well plate, were transfected with the wild-
type or mutated Bmal1 promoter/luciferase constructs (400 ng each) and co-
transfected with expression plasmids for PPARg, RXRa, and b-galactosidase
(200 ng each) using Fugene HD (Roche) according to the manufacturer’s pro-
tocol. At 24 hr after transfection, cells were treated for 24 hr with 2 mM RGZ or
DMSO (vehicle). Luciferase activities were measured with luciferase assay re-
agent (Promega) using a Lumat LB9501 luminometer (Berthold System, Inc.,
Pittsburgh) and were normalized by b-galactosidase activity.
Catecholamine Assay
Urine was collected in a vial containing 10–15 ml of 6 M HCl during the light
phase (CT0–12) and dark phase (CT12–24) and was stored at 20C before
the assay. Urinary Epi and NE were measured by using a commercially avail-Cellable enzyme immunoassay kit (Bi-CAT EIA, ALPCO Diagnostics, Salem, NH)
according to the manufacturer’s instructions.
Statistical Analysis
All values are presented as mean ± SE two-way ANOVA and Bonferroni post-
tests were used for comparisons among multiple groups and the unpaired
Student’s t test for comparisons between two groups. Differences were con-
sidered to be significant when the P value was less than 0.05.
SUPPLEMENTAL DATA
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